MedTrace Logo

Gastric Volume After Ingestion of Carbohydrate Drink vs Water in Obese Volunteers

NCT05827029 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-04-24

No results posted yet for this study

Summary

This randomized crossover study compares gastric residual volume after ingestion of carbohydrate drinks and water in obese volunteers. The main question\[s\] it aims to answer are:

* Is it safe for obese patients to shorten their fasting by allowing preoperative drinks?
* How long is the gastric emptying time in obese patients? Participants also will be evaluated the level of thirst/hungry and blood sugar.

Conditions

Interventions

PROCEDURE

Preopertive drink

* Group C: will receive a carbohydrate drink of 400 ml (50 g of glucose prepared by nutrition division, same appearance and containing bottles of water) * Group W: will receive water 400 ml (prepared by nutrition division, Songklanagarind hospital, same appearance and containing bottles of carbohydrate drink) In both groups, the received 400-mL drink was consumed within 5 minutes. * Before drinking, baseline data (gastric residual volume, POCT glucose, degree of hunger, and thirst) will be evaluated. * Gastric ultrasound will be performed by the same Radiologist on each participant at 0, 30, 60, 90, 120 minutes * after drinking to evaluate the gastric residual volume and time to empty gastric antrum. * POCT glucose and degree of hunger and thirst are also assessed again at 120 minutes after drinking. * After completing one type of drinking, participants will be appointed again after 1 week later for doing the same protocol with another drinking.

Sponsors & Collaborators

  • Prince of Songkla University

    lead OTHER

Principal Investigators

  • Chanatthee Kitsiripant · Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05827029 on ClinicalTrials.gov